YHLO

Focus on healthcare, better life with technology In May of 2021, YHLO has successfully launched IPO and listed on Shanghai Stock Exchange (Stock code: 688575).

YHLO (EST. 2008) is an innovative and steadfastly growing company of immunoassay solutions headquartered in Shenzhen, China, specialized in developing, manufacturing and distributing in-vitro diagnostic instruments and reagents by a team of experienced scientists and engineers.

30/09/2025

🏆 The Six Thrombosis Parameters

Blood clot formation and breakdown are complex processes that require accurate, timely assessment. YHLO brings together six essential biomarkers—TAT, PIC, TM, t-PAIC, D-Dimer, and FDP—to give clinicians a comprehensive view of thrombosis risk and progression.

This combined panel supports early detection of clot formation, monitoring of thrombolytic therapy, and better management of DIC and related conditions. It also offers valuable insights for preventative health checks and risk screening.

🔗 For more information, please visit: https://en.szyhlo.com/

29/09/2025

💡 FDP – Reflecting Fibrinolytic Function

FDP is an important marker of fibrinolysis, widely used in diagnosing DIC and monitoring patients after surgery. Elevated FDP levels can indicate conditions such as hyperfibrinolysis, kidney disease, myocardial infarction, DVT, or complications during chemotherapy.

YHLO’s FDP assay, powered by our CLIA platform, provides accurate and consistent results to support both diagnosis and follow-up in thrombotic and fibrinolytic disorders.

🔗 For more information, please visit: https://en.szyhlo.com/

26/09/2025

🌿 t-PAIC Assay – Enhancing Thrombosis Care

YHLO’s t-PAIC assay provides clinicians with valuable insights into venous thromboembolism (VTE), myocardial infarction risk, and endothelial recovery. Elevated levels are also associated with DIC, eclampsia, and obesity, making it a versatile tool in clinical practice.

Powered by YHLO’s CLIA platform, the assay delivers accurate and consistent results to support better patient care.

For more information, please visit: https://en.szyhlo.com/

25/09/2025

💡Thrombomodulin (TM) – Reflecting Endothelial Function

Thrombomodulin (TM) is a key molecule that captures thrombin and helps regulate both anticoagulant and anti-inflammatory pathways. Elevated TM levels reflect endothelial injury or dysfunction, which may occur in conditions such as diabetes, kidney disease, ARDS, liver failure, and atherosclerosis.

YHLO’s TM assay provides clinicians with valuable insights into vascular health, supporting early detection, prognosis, and better management of cardiovascular and systemic diseases.

For more information, please visit: https://en.szyhlo.com/

,

24/09/2025

🧪 PIC – For the Diagnosis and Monitoring of Thrombosis

The Plasmin-Antiplasmin Complex (PIC) is an important biomarker for detecting Disseminated Intravascular Coagulation (DIC) and other thrombotic conditions. Measuring PIC levels helps clinicians diagnose disease early, assess risks linked to surgery or tumors, and identify complications such as pre-eclampsia.

YHLO’s PIC assay delivers reliable results to support both diagnosis and ongoing monitoring, helping improve treatment strategies and patient outcomes.

For more information, please visit: https://en.szyhlo.com/

22/09/2025

🩸 TAT – Tracking Thrombosis Activity

Thrombin-Antithrombin Complex (TAT) is a sensitive marker that reflects thrombin generation and clotting activity. Elevated TAT levels are closely associated with disseminated intravascular coagulation (DIC), deep vein thrombosis (DVT), and pulmonary embolism (PE).

YHLO’s TAT assay supports clinicians in detecting early thrombosis, monitoring prognosis, and evaluating the effectiveness of anticoagulant therapy, especially in post-thrombosis care.

🔗 For more information, please visit: https://en.szyhlo.com/

19/09/2025

💡 Screening Indicators for Secondary Hypertension

Secondary hypertension often results from underlying hormonal or adrenal conditions. YHLO provides a panel including Cortisol, ACTH, Aldosterone, and Renin to support accurate screening and classification.

With this integrated approach, clinicians can improve the diagnosis of conditions such as Cushing’s syndrome, primary aldosteronism, and renovascular hypertension, while also guiding personalized treatment for hereditary forms of hypertension.

For more information, please visit: https://en.szyhlo.com/

17/09/2025

⚖️ Aldosterone – Balancing Blood Pressure and Electrolytes

Aldosterone is a vital hormone for regulating blood pressure and salt–water balance. YHLO’s ALD assay helps clinicians identify adrenal disorders such as hyperaldosteronism, adrenal insufficiency, and congenital conditions. It also supports treatment decisions in hypertension and heart failure by monitoring the effectiveness of therapy.

For more information, please visit: https://en.szyhlo.com/

15/09/2025

💡 Renin – Unlocking the Mechanisms of Blood Pressure

Renin plays a critical role in regulating blood pressure and electrolyte balance. YHLO’s renin assay provides clinicians with reliable results to support the diagnosis of hypertension, adrenal disorders, and rare renin-secreting tumors, helping guide tailored treatment strategies and improving clinical decision-making.

For more information, please visit: https://en.szyhlo.com/

13/09/2025

🌍 World Sepsis Day | September 13, 2025

On this World Sepsis Day, let’s raise awareness together, strengthen diagnostic capacity, and protect lives through science.

Sepsis remains one of the world’s deadliest conditions, affecting more than 47 million people annually and claiming millions of lives. Caused by uncontrolled infection, sepsis can progress rapidly — making early recognition and timely intervention critical.

At YHLO, we are committed to supporting clinicians with advanced diagnostic solutions. Our iFlash CLIA platform offers reliable assays for key sepsis biomarkers:

🔹 PCT

🔹 IL-6

🔹 CRP

🔗 Learn more about YHLO: https://en.szyhlo.com

12/09/2025

🧬 ACTH – The Messenger Between Brain and Adrenals

Adrenocorticotropic Hormone (ACTH) is central to the communication between the 🧠 brain and adrenal glands, forming a vital part of the hypothalamic–pituitary–adrenal (HPA) axis.

Measuring ACTH levels helps clinicians understand adrenal function precisely. It is an essential marker for supporting accurate endocrine evaluation.

For more information, please visit: https://en.szyhlo.com/

10/09/2025

🌟 Cortisol – A Key Marker of Adrenal Function

Cortisol testing helps assess adrenal health, aiding in the diagnosis of adrenal insufficiency, functional disorders, and Cushing’s syndrome. It provides essential insights into the overall status of adrenal and pituitary function.

For more information, please visit: https://en.szyhlo.com/

Address

YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict
Shenzhen
518000

Telephone

+8675526601910

Website

https://en.szyhlo.com/

Alerts

Be the first to know and let us send you an email when YHLO posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to YHLO:

Shortcuts

Want your practice to be the top-listed Clinic in Shenzhen?